Senestech, Inc. (NASDAQ:SNES) Sees Large Decline in Short Interest

Senestech, Inc. (NASDAQ:SNESGet Free Report) saw a large decline in short interest in the month of July. As of July 15th, there was short interest totaling 27,608 shares, a decline of 49.7% from the June 30th total of 54,875 shares. Currently, 0.5% of the shares of the company are sold short. Based on an average daily volume of 64,738 shares, the days-to-cover ratio is currently 0.4 days.

Senestech Stock Performance

NASDAQ:SNES traded down $0.03 on Thursday, reaching $1.24. 3,507 shares of the company’s stock were exchanged, compared to its average volume of 60,841. The firm has a market cap of $6.57 million, a price-to-earnings ratio of -0.66 and a beta of 0.28. The company has a debt-to-equity ratio of 0.02, a current ratio of 8.91 and a quick ratio of 7.79. The stock has a fifty day simple moving average of $1.55 and a 200-day simple moving average of $1.75. Senestech has a 52 week low of $1.22 and a 52 week high of $6.24.

Senestech (NASDAQ:SNESGet Free Report) last posted its quarterly earnings results on Tuesday, May 12th. The company reported ($0.31) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.33) by $0.02. Senestech had a negative net margin of 304.22% and a negative return on equity of 67.60%. The company had revenue of $0.49 million for the quarter, compared to analyst estimates of $0.63 million. As a group, sell-side analysts predict that Senestech will post -1.57 earnings per share for the current year.

Insider Buying and Selling

In other news, major shareholder Glenbrook Capital Management acquired 35,000 shares of the company’s stock in a transaction that occurred on Monday, July 20th. The shares were acquired at an average price of $1.47 per share, for a total transaction of $51,450.00. Following the completion of the purchase, the insider owned 1,057,824 shares in the company, valued at approximately $1,555,001.28. This trade represents a 3.42% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders purchased a total of 143,773 shares of company stock valued at $224,802 in the last quarter. 2.20% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Senestech

Large investors have recently made changes to their positions in the stock. Diversify Wealth Management LLC purchased a new position in shares of Senestech in the first quarter valued at $31,000. Jane Street Group LLC purchased a new stake in Senestech during the 4th quarter worth about $32,000. Diversify Advisory Services LLC bought a new position in Senestech in the 4th quarter worth about $34,000. XTX Topco Ltd bought a new position in Senestech in the 4th quarter worth about $54,000. Finally, Geode Capital Management LLC purchased a new position in Senestech during the 2nd quarter valued at about $59,000. 5.19% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings raised Senestech from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, July 10th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold”.

Check Out Our Latest Report on Senestech

About Senestech

(Get Free Report)

SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.

The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.

See Also

Receive News & Ratings for Senestech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senestech and related companies with MarketBeat.com's FREE daily email newsletter.